Clinical Trials Logo

Clinical Trial Summary

Background:

- Glucocorticoids are primary stress response hormones released from the adrenal gland when an individual is under stress. Chronic or ongoing elevation of these hormones due to prolonged stress or medical treatments can have numerous harmful effects. Researchers are interested in learning more about how these hormones affect cell growth, development, and death. To study glucocorticoid hormones, researchers plan to use the medication dexamethasone, which affects the parts of cells that respond to glucocorticoid hormones.

Objectives:

- To study glucocorticoid stress hormones in healthy individuals before and after receiving dexamethasone.

Eligibility:

- Healthy individuals at least 18 years of age.

- Participants must not be using certain medications that may affect the dexamethasone test, including hormonal contraception, steroid-based drugs, and some antidepressants.

Design:

- This study will require an initial screening visit and a second study visit. The visits are estimated to require about 1 to 2 hours of participation over a period of up to 14 days.

- Participants will be screened at visit 1 with a full physical examination and medical history, and an initial blood sample for testing.

- For visit 2, participants will be asked to abstain from all food and drinks except for water for 12 hours before the appointment, and will take one tablet of dexamethasone 9 hours before the appointment.

- Participants will have a second blood sample taken during visit 2, and will receive a snack after the blood is drawn.


Clinical Trial Description

STUDY DESIGN:

This in vivo and in vitro observational gene association study will investigate the functional relevance of SNPs in the NR3C1 gene in selected populations. A subgroup of the EPR will be genotyped to identify novel SNPs in the NR3C1 gene. The most promising SNPs for functional relevance in in vitro assays will be examined. Individuals with and without functionally relevant, novel SNPs will be recruited for further study. In part 1, lymphocytes from these participants will be isolated, exposed ex vivo to corticosteroids, and gene expression profiles in response to this stimulus will be compared. In part 2, in vivo effect of these SNPs in steroid responsiveness will be evaluated by performing a modified low dose dexamethasone suppression test comparing by genotype. The study design is innovative as a gene association study in the sense that participants are recruited on the basis of genotype and then the phenotype of each participant is observed.

STUDY DURATION:

It is anticipated that the study will require 48 months to complete participants study visits.

PRIMARY OBJECTIVE:

Investigate in vivo the role of hGR SNPs (hGR9beta A3669B, hGR N363S) in steroid responsiveness by performing a modified dexamethasone suppression test and comparing responses by genotype.

SECONDARY OBJECTIVE:

Investigate the role of hGR SNPs (hGR9beta A3669B, hGR N363S) in human steroid responsiveness by comparing (across genotypes) gene expression profiles of isolated macrophages and lymphocytes exposed ex vivo to corticosteroids.

PRIMARY ENDPOINT:

Measure the change in serum cortisol levels after modified dexamethasone suppression test.

SECONDARY ENDPOINT:

Measure gene expression fold changes by microarray analysis after ex vivo glucocorticoid exposure of macrophages and lymphocytes; validation of affected RNA (elevated or decreased expression) through PCR analysis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01143493
Study type Observational
Source National Institutes of Health Clinical Center (CC)
Contact
Status Completed
Phase
Start date September 30, 2010
Completion date December 2, 2019

See also
  Status Clinical Trial Phase
Completed NCT03577223 - Egg Effects on the Immunomodulatory Properties of HDL N/A
Completed NCT03689738 - Effects of Potato Resistant Starch Intake on Insulin Sensitivity, Related Metabolic Markers and Satiety N/A
Completed NCT00905892 - Metabolic Fate Modifications of Saturated Fats After an Overfeeding N/A
Completed NCT03270527 - RISSCI-1 Blood Cholesterol Response Study N/A
Completed NCT01779245 - Effect of High-calcium Intake on Substrate Metabolism During Exercise N/A
Completed NCT03324191 - Tea Extract, Blood Lipid and Dietary Fat N/A
Completed NCT03757767 - The Fasting Study - Unraveling the Mechanistic Effects of Prolonged Fasting in Humans. N/A
Completed NCT05282641 - Effects of 10-gram Collagen Protein Hydrolysate on Cardiometabolic Health N/A
Completed NCT04748432 - Lipid Kinetics of Patients With Pneumonia
Completed NCT03648112 - Effects of Beta-glucan From Barley and Oats on Glucose and Lipid Metabolism, and Satiety N/A
Recruiting NCT04851041 - Effects of a Potato-based Food Pattern vs a Rice / Pasta-based Food Pattern on Cardiometabolic Health N/A
Completed NCT05313594 - Digital Twin - Modelling Postprandial Triglyceride and Glucose Responses
Terminated NCT05297032 - Effects of Quercetin on Metabolic Health N/A
Completed NCT05297825 - Twins Nutrition Study (TwiNS): Vegan vs. Omnivore N/A
Recruiting NCT03287518 - Evaluation of the Benefit and Tolerability of WAK2017 on Endothelial Function, Blood Pressure and Lipid Profile N/A
Completed NCT00227500 - Pravastatin for Hyperlipidaemia in HIV. Phase 4
Recruiting NCT04894526 - Alternating Energy Intake and Blood Fat Content After a Meal N/A
Completed NCT03029364 - Body Composition and Lipid Metabolism at Rest and During Exercise: A Cross-Sectional Analysis.
Completed NCT01921075 - Physiologic Plasticity of Intramyocardial Lipid Storage N/A
Completed NCT00620360 - Acute Effect of Fructose on Lipid Metabolism and Gender Differences N/A